The DOI matches its Crossref record.
Anti‐eosinophil activity and clinical efficacy of the CRTH 2 antagonist OC 000459 in eosinophilic esophagitis
Abstract
Background: Eosinophilic esophagitis (E o E) is a chronic, T h2‐type inflammatory disease. Chemoattractant receptor‐homologous molecule on Th2 cells (CRTH 2) is a prostaglandin D2 (PGD2) receptor, expressed by Th2 cells and other inflammatory cells, including eosinophils and basophils, that mediates chemotaxis and activation. OC 000459 is a selective CRTH 2 antagonist and would be expected to suppress eosinophilic tissue inflammation. The purpose of this study was to evaluate the efficacy and safety of an OC 000459 monotherapy in adult patients with active, corticosteroid‐dependent or corticosteroid‐refractory E o E. Methods: In this randomized, double‐blind, placebo‐controlled trial, 26 adult patients (m/f = 22/4; mean age 41 years, range 22–69 years) with active E o E, dependent or resistant to corticosteroids, were treated either with 100 mg OC 000459 (n = 14) or placebo (n = 12) twice daily. Pre‐ and post‐treatment disease activity was assessed clinically, endoscopically, histologically, and via biomarkers. The primary end point was the reduction in esophageal eosinophil infiltration. Results: After an 8‐week OC 000459 treatment, the esophageal eosinophil load decreased significantly, from 114.83 to 73.26 eosinophils per high‐power field [(eos/hpf), P = 0.0256], whereas no reduction was observed with placebo (102.80–99.47 eos/hpf, P = 0.870). With OC 000459, the physician's global assessment of disease activity improved from 7.13 to 5.18 (P = 0.035). OC 000459 likewise reduced extracellular deposits of eosinophil peroxidase and tenascin C, the effects not seen with placebo. No serious adverse events were observed. Conclusions: An 8‐week treatment with the CRTH 2‐antagonist, OC 000459, exerts modest, but significant, anti‐eosinophil and beneficial clinical effects in adult patients with active, corticosteroid‐dependent or corticosteroid‐refractory EoE and is well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pathophysiology of Eosinophilic Esophagitis
O’Shea, K. M., Aceves, S. S., Dellon, E. S., Gupta, S. K., Spergel, J. M., Furuta, G. T., & Rothenberg, M. E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.06.065 · Cited by 502
Lipid mediators and allergic diseases
Fanning, L. B., & Boyce, J. A. (2013) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2013.06.031 · Cited by 70
Latest developments in allergic rhinitis in Allergy for clinicians and researchers
Ng, C. L., & Wang, D. Y. (2015) · Allergy · doi:10.1111/all.12782 · Cited by 21
Revisiting Therapies for Atopic Dermatitis that Failed Clinical Trials
Agnihotri, G., & Lio, P. A. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00905-7 · Cited by 15
Metadata
- Authors
- Straumann, A., Hoesli, S., Bussmann, C., Stuck, M., Perkins, M., Collins, L. P., Payton, M., Pettipher, R., Hunter, M., Steiner, J., & Simon, H. ‐.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2013-02-05
- Volume
- 68
- Issue
- 3
- Pages
- 375-385
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2092078565
- Cited by
- 207
- References
- 0
- FWCI
- 23.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.